跳至主要内容
临床试验/ITMCTR2100005116
ITMCTR2100005116招募中1 期

Clinical effect and mechanism of Shen'an decoction in the treatment of diabetic kidney disease: a randomized controlled clinical study protocol

Changchun University of Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
1 期
状态
招募中

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
18 至 65(—)
性别
All

入选标准

  • 1.At the same time, it meets the diagnostic criteria and syndrome differentiation criteria of Chinese medicine, and the diagnostic criteria of Western medicine for diabetic nephropathy;
  • 2.The gender is not limited, and the aged 18 to 65 years;
  • 3.HbA1c<=7%, for patients with severe complications such as recurrent hypoglycemia, severe microvascular or macrovascular complications, or patients who cannot meet the standard requirements after adequate treatment, HbA1c<=8%.
  • 4.Control blood pressure below 130/80mmHg;
  • 5.The patient knows and voluntarily participates in the trial study and signs the consent form, and has good compliance.

排除标准

  • 1.Patients with mental illness who cannot cooperate with treatment and cannot follow the doctor's instructions to receive treatment on time;
  • 2.Patients with recent acute complications and co-infection;
  • 3.Women who are pregnant or breastfeeding or who are about to conceive;
  • 4.People who are prone to allergies or are allergic to test drugs;
  • 5.Patients who have undergone hemodialysis and kidney transplantation;
  • 6.Patients with acute metabolic dysfunction complications such as diabetic ketoacidosis and hyperosmolar coma in the past month;
  • 7.Suffer from other primary or secondary kidney diseases, or other diseases that can cause increased urine protein.

研究者

相似试验